Becker's Healthcare September 16, 2024
Elizabeth Gregerson

The market for radiopharmaceuticals has the potential to grow to “tens of billions” if the drugs prove to be effective, according to a Sept. 16 report from CNBC.

Companies including Bristol Myers Squibb, AstraZeneca and Eli Lilly have invested billions in radiopharmaceutical drugs, which target cells containing specific cancer markers with radioactive material, the report said.

“If we can be successful in expanding the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article